Skip to main navigation
  • HOME
  • ABOUT ENZON
  • ROYALTY PRODUCTS
  • INVESTORS & MEDIA

    Investor Relations

    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Lookup
    • Contact Us
  • CONTACT US
  • Request Information
  • Email Alerts
  • Download Library
  • RSS News Feeds
Shareholder Tools
Downloads
Print

Downloads

Jun 22, 2009
Enzon Commences Phase II Trial of PEG-SN38 13.7 KB
Jun 01, 2009
Enzon Presents Clinical Data from HIF-1 Alpha Antagonist Study at ASCO 13.5 KB
May 21, 2009
Enzon Stockholders Approve Company Proposals at 2009 Annual Meeting 9.7 KB
May 14, 2009
UCB's Cimzia(R) Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis 11.9 KB
May 07, 2009
Enzon Reports Strong 1st Quarter 2009 Results 36.1 KB
May 06, 2009
Enzon Reaches Phase II Dose for PEG-SN38 10.5 KB
Apr 29, 2009
Enzon to Release First Quarter 2009 Earnings on Thursday, May 7, 2009; Conference Call and Webcast to Follow 9.7 KB
Apr 23, 2009
Enzon Continues to Improve Its Capital Structure 9.8 KB
Apr 23, 2009
Enzon's Board of Directors Reaffirms Support of Its Chairman and CEO 18.4 KB
Apr 14, 2009
2008 Annual Report 2.2 MB

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page next ›
  • Last page last »

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.